These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36413031)

  • 1. Efficacy and Safety of Anti-Xa-Guided Versus Fixed Dosing of Low Molecular Weight Heparin for Prevention of Venous Thromboembolism in Trauma Patients: A Systematic Review and Meta-Analysis.
    Tran A; Fernando SM; Gates RS; Gillen JR; Droege ME; Carrier M; Inaba K; Haut ER; Cotton B; Teichman A; Engels PT; Patel RV; Lampron J; Rochwerg B
    Ann Surg; 2023 May; 277(5):734-741. PubMed ID: 36413031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Low Molecular Weight Heparin Versus Unfractionated Heparin for Prevention of Venous Thromboembolism in Trauma Patients: A Systematic Review and Meta-analysis.
    Tran A; Fernando SM; Carrier M; Siegal DM; Inaba K; Vogt K; Engels PT; English SW; Kanji S; Kyeremanteng K; Lampron J; Kim D; Rochwerg B
    Ann Surg; 2022 Jan; 275(1):19-28. PubMed ID: 34387202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
    Di Nisio M; Porreca E; Candeloro M; De Tursi M; Russi I; Rutjes AW
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD008500. PubMed ID: 27906452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is There a Role for Anti-factor Xa Activity Assay in Venous Thromboembolism Prophylaxis Management Among Orthopaedic Trauma Patients? Systematic Review and Meta-analysis.
    Tischler EH; Tsai SHL; Wolfert AJ; von Keudell A; Roudnitsky V; Gross J; Suneja N
    J Orthop Trauma; 2023 Sep; 37(9):e368-e376. PubMed ID: 37053117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low molecular weight heparin versus other anti-thrombotic agents for prevention of venous thromboembolic events after total hip or total knee replacement surgery: a systematic review and meta-analysis.
    Lu X; Lin J
    BMC Musculoskelet Disord; 2018 Sep; 19(1):322. PubMed ID: 30193575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy.
    Perrotta C; Chahla J; Badariotti G; Ramos J
    Cochrane Database Syst Rev; 2020 May; 5(5):CD005259. PubMed ID: 32374919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary prophylaxis for venous thromboembolism in people undergoing major amputation of the lower extremity.
    Herlihy DR; Thomas M; Tran QH; Puttaswamy V
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD010525. PubMed ID: 32692430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
    Di Nisio M; Porreca E; Otten HM; Rutjes AW
    Cochrane Database Syst Rev; 2014 Aug; (8):CD008500. PubMed ID: 25171736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulation for people with cancer and central venous catheters.
    Kahale LA; Tsolakian IG; Hakoum MB; Matar CF; Barba M; Yosuico VE; Terrenato I; Sperati F; Schünemann H; Akl EA
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006468. PubMed ID: 29856471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor Xa Inhibitors and Direct Thrombin Inhibitors Versus Low-Molecular-Weight Heparin for Thromboprophylaxis After Total Hip or Total Knee Arthroplasty: A Systematic Review and Meta-Analysis.
    Sun G; Wu J; Wang Q; Liang Q; Jia J; Cheng K; Sun G; Wang Z
    J Arthroplasty; 2019 Apr; 34(4):789-800.e6. PubMed ID: 30685261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between anti-Xa level achieved with prophylactic low-molecular weight heparin and venous thromboembolism in trauma patients: A systematic review and meta-analysis.
    Verhoeff K; Raffael K; Connell M; Kung JY; Strickland M; Parker A; Anantha RV
    J Trauma Acute Care Surg; 2022 Aug; 93(2):e61-e70. PubMed ID: 35195094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological interventions for preventing venous thromboembolism in people undergoing bariatric surgery.
    Amaral FC; Baptista-Silva JC; Nakano LC; Flumignan RL
    Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013683. PubMed ID: 36413425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
    Di Nisio M; Porreca E; Ferrante N; Otten HM; Cuccurullo F; Rutjes AW
    Cochrane Database Syst Rev; 2012 Feb; (2):CD008500. PubMed ID: 22336844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral direct Factor Xa inhibitors versus low-molecular-weight heparin to prevent venous thromboembolism in patients undergoing total hip or knee replacement: a systematic review and meta-analysis.
    Neumann I; Rada G; Claro JC; Carrasco-Labra A; Thorlund K; Akl EA; Bates SM; Guyatt GH
    Ann Intern Med; 2012 May; 156(10):710-9. PubMed ID: 22412038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-molecular-weight heparin is associated with lower venous thromboembolism events than factor Xa inhibitors in patients with severe blunt trauma: a cohort study from the Trauma Quality Improvement Program.
    Chan SY; Huang JF; Cheng CT; Hsu CP; Liao CH; Fu CY
    Int J Surg; 2024 Jan; 110(1):280-286. PubMed ID: 37738013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin for the prevention of venous thromboembolism in acutely ill medical patients (excluding stroke and myocardial infarction).
    Alikhan R; Bedenis R; Cohen AT
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD003747. PubMed ID: 24804622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.
    Felder S; Rasmussen MS; King R; Sklow B; Kwaan M; Madoff R; Jensen C
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD004318. PubMed ID: 30916777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low molecular weight heparin for prevention of venous thromboembolism in patients with lower-limb immobilization.
    Zee AA; van Lieshout K; van der Heide M; Janssen L; Janzing HM
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD006681. PubMed ID: 28780771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary prophylaxis for venous thromboembolism in people undergoing major amputation of the lower extremity.
    Robertson L; Roche A
    Cochrane Database Syst Rev; 2013 Dec; (12):CD010525. PubMed ID: 24343728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.
    Felder S; Rasmussen MS; King R; Sklow B; Kwaan M; Madoff R; Jensen C
    Cochrane Database Syst Rev; 2019 Aug; 8(8):CD004318. PubMed ID: 31449321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.